The horse cardiac transcriptome: Moving towards a molecular understanding of atrial fibrillation
Authors:
- Simon Libak HaugaardSHSimon Libak Haugaard
- Sarah Dalgas NissenSNSarah Dalgas Nissen
- Mélodie Jil SchneiderMSMélodie Jil Schneider
- Jesper Bratz BirkJBJesper Bratz Birk
- Helena CarstensenHCHelena Carstensen
- Charlotte Hopster‐IversenCHCharlotte Hopster‐Iversen
- Ali AltıntaşAAAli Altıntaş
- Romain BarrèsRBRomain Barrès
- Rasmus KjøbstedRasmus Kjøbsted
- Jørgen F. P. WojtaszewskiJWJørgen F. P. Wojtaszewski
- Thomas JespersenTJThomas Jespersen
- 14 November 2025
- journal article
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (5) , 1319-1335
Abstract
Background: High recurrence rates after atrial fibrillation (AF) treatment may be driven by myocardial changes induced by the arrhythmia itself. Understanding the molecular mechanisms behind these changes is crucial for developing targeted therapies and improving outcomes. Objectives: To characterise the cardiac transcriptome of healthy horses and explore transcriptional changes associated with persistent AF (naturally occurring and tachypacing‐induced). Study Design: Case–control study. Methods: RNA ‐sequencing was performed on atrial and ventricular tissue samples collected from six horses with naturally occurring persistent AF (lasting 2–12 weeks) and six healthy controls. Differential gene expression and pathway enrichment analyses were conducted to identify chamber‐specific differences and molecular pathways associated with AF . Findings were integrated with proteomic data and compared with transcriptional changes in a separate cohort of 10 horses with tachypacing‐induced AF . Atrial metabolic remodelling was further investigated by evaluating the activity of AMP ‐activated protein kinase ( AMPK ), a central metabolic regulator and measuring local glycogen content. Results: The transcriptomes of the four heart chambers had distinct molecular identities. Expression of ion channels and genes encoding calcium handling proteins was largely similar to humans, despite important differences in the ventricular expression of repolarising potassium channels. Persistent AF was associated with minimal ion channel changes but significant upregulation of metabolic, fibrotic and myofibrillar pathways. Metabolic remodeling included upregulation of fatty acid and glycolytic pathways, increased glycogen content in the left atrium and preserved AMPK activity in the right atrium. Transcriptomic profiles of naturally occurring persistent AF correlated well with those of tachypacing‐induced AF . Main Limitations: The study cannot distinguish changes predisposing to AF from those caused by it. Conclusion: Persistent AF was associated with changes in metabolic and fibrotic pathways in the atria, with minimal ion channel remodeling. Targeting these pathways, rather than focusing solely on the electrical disturbance, may improve treatment outcomes in equine AF.Keywords
All Related Versions
Funding Information
- Danmarks Frie Forskningsfond (1032‐00053B)
This publication has 83 references indexed in Scilit:
- NR4A3 prevents diabetes induced atrial cardiomyopathy by maintaining mitochondrial energy metabolism and reducing oxidative stressEBioMedicine, 2024
- Human cardiac metabolismCell Metabolism, 2024
- Heart Rate and Rhythm2023
- Regulation of cardiac ion channels by transcription factors: Looking for new opportunities of druggable targets for the treatment of arrhythmiasBiochemical Pharmacology, 2022
- Kallistatin/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
- Alpha and beta myosin isoforms and human atrial and ventricular contractionCellular and Molecular Life Sciences, 2021
- Linking cellular energy state to atrial fibrillation pathogenesis: Potential role of adenosine monophosphate–activated protein kinaseHeart Rhythm, 2020
- Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horsesHeart Rhythm, 2015
- A Collection of Enzyme Assays1993
- Cardiac interstitium in health and disease: The fibrillar collagen networkJACC, 1989